In vitro cell motility as a potential mesenchymal stem cell marker for multipotency

Area of Science:

• Cell Biology
• Regenerative Medicine
• Biotechnology

Background:

• Mesenchymal stem cells (MSCs) are crucial for cell-based therapies due to their proliferation, differentiation, and immunomodulatory capabilities.
• Donor variability in MSCs leads to inconsistent therapeutic outcomes, necessitating robust characterization methods.
• Existing methods for MSC characterization are insufficient to address inherent donor variability.

Purpose of the Study:

• To investigate in vitro cell motility as a method for characterizing human mesenchymal stem cell (MSC) populations.
• To correlate MSC motility patterns with differentiation potential, senescence, and cell size.
• To assess the utility of live imaging for predicting MSC quality and therapeutic efficacy.

Main Methods:

• Live imaging was used to measure the track lengths of 70 mesenchymal stem cells (MSCs) per population over 24 hours.
• In vitro motility of bone marrow MSCs from various donors and passages was analyzed.
• Motility data were correlated with adipogenic, chondrogenic, and osteogenic differentiation potentials, senescence levels, and cell size.

Main Results:

• Slow-moving MSCs exhibited higher senescence rates, while larger cells showed reduced motility.
• Fast- and slow-moving MSC populations demonstrated lower differentiation potential compared to average-moving cells.
• Heterogeneity in single-cell motility within a population correlated with average-moving cells, indicating potential for better differentiation.

Conclusions:

• In vitro cell motility is a viable tool for rapid characterization of mesenchymal stem cell (MSC) populations.
• Motility analysis can predict MSC differentiation potential, aiding in the selection of suitable cells for therapy.
• Live imaging of MSC motility offers a promising approach to mitigate donor variability issues in cell-based therapies.